Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr;25(2):132-137.
doi: 10.1097/MCC.0000000000000589.

Pharmacotherapy of sodium disorders in neurocritical care

Ségolène Mrozek  1 , David Rousset, Thomas Geeraerts
Affiliations

Pharmacotherapy of sodium disorders in neurocritical care

Ségolène Mrozek et al. Curr Opin Crit Care. 2019 Apr.

Abstract

Purpose of review: To describe the pathophysiology and pharmacotherapy of dysnatremia in neurocritical care patients.

Recent findings: Sodium disorders may affect approximately half of the neurocritical care patients and are associated with worse neurological outcome and increased risk of death. Pharmacotherapy of sodium disorders in neurocritical care patients may be challenging and is guided by a careful investigation of water and sodium balance.

Summary: In case of hyponatremia, because of excessive loss of sodium, fluid challenge with isotonic solution, associated with salt intake is the first-line therapy, completed with mineralocorticoids if needed. In case of hyponatremia because of SIADH, fluid restriction is the first-line therapy followed by urea if necessary. Hypernatremia should always be treated with hypotonic solutions according to the free water deficit, associated in case of DI with desmopressin. The correction speed should take into consideration the symptoms associated with dysnatremia and the rapidity of the onset.

PubMed Disclaimer

Publication types